Atlas Trials

A Phase II Study of H021 Enteric-coated Tablets for Moderately to Severely Active Crohn's Disease

Clinical trial NCT07677514 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07677514
Sponsor
Jiangsu Carephar Pharmaceutical Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Crohn's Disease
Start date
2026-07-12
Primary completion
2026-10-12
Enrollment
156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.